Development and Evaluation of Functional Probiotic Powder in Human Trials
FPPHT
Functional Probiotic Powder Human Trials
2 other identifiers
interventional
60
0 countries
N/A
Brief Summary
Purpose: To optimize the preparation process of probiotic powder and assess its impact on healthy athletes, providing a scientific basis for functional foods. Procedures: Probiotic Powder Preparation: Using vacuum freeze-drying to improve bacterial survival rates. Human Trials: Recruiting healthy athletes aged 20-30, divided into placebo and probiotic powder groups for an 8-week trial. Testing and Analysis: Conducting running exhaustion tests and blood biochemical analysis to evaluate the effects of probiotic powder. Importance: Understanding the effects of probiotics on athletes helps develop better health products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2024
CompletedFirst Posted
Study publicly available on registry
January 6, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJanuary 6, 2025
January 1, 2025
3 months
December 26, 2024
January 3, 2025
Conditions
Outcome Measures
Primary Outcomes (8)
Lactic acid
Lactic acid:Collecting 2 ml of venous blood for measurement indicators
8 weeks
Creatine kinase
Creatine kinase: Collecting 2 ml of venous blood for measurement indicators.
8 weeks
Blood urea nitrogen
Blood urea nitrogen: Collecting 2 ml of venous blood for measurement indicators.
8 weeks
Liver glycogen
Liver glycogen: Collecting 2 ml of venous blood for measurement indicators.
8 weeks
Muscle glycogen
Muscle glycogen: Collecting 2 ml of venous blood for measurement indicators.
8 weeks
Total superoxide dismutase
Total superoxide dismutase: Collecting 2 ml of venous blood for measurement indicators.
8 weeks
Glutathione
Glutathione: Collecting 2 ml of venous blood for measurement indicators.
8 weeks
Malondialdehyde
Malondialdehyde
8 weeks
Secondary Outcomes (1)
Maximum Oxygen Uptake
8 weeks
Study Arms (2)
Experimental group
EXPERIMENTALRandomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the experimental group. Participants in the experimental group will undergo an 8-week probiotic powder supplementation intervention. The dosage of the probiotic powder is set at 1x10\^9 CFU/kg·bw·d, which means ingesting 10 billion CFU (Colony-Forming Units) of probiotics per kilogram of body weight per day. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the probiotic powder once a day at the same time to ensure the consistency of the dosage and the standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise capacity tests and blood sample collections will be condu
Control group
NO INTERVENTIONDescription: Arm Description: Randomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the control group. Participants in the control group will undergo an 8-week placebo supplementation intervention. The placebo has a similar appearance and taste to the probiotic powder but does not contain active probiotic ingredients. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the placebo once a day at the same time to ensure the consistency and standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise capacity tests and blood sample collections will be conducted again. Comparing exercise perf
Interventions
Arm Description: Randomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the control group. Participants in the control group will undergo an 8-week placebo supplementation intervention. The placebo has a similar appearance and taste to the probiotic powder but does not contain active probiotic ingredients. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the placebo once a day at the same time to ensure the consistency and standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise capacity tests and blood sample collections will be conducted again. Comparing exercise performance and biochemical markers before and after t
Experimental: Arm Description: Randomly select 30 healthy and well-trained athletes aged between 20 and 30 to serve as the experimental group. Participants in the experimental group will undergo an 8-week probiotic powder supplementation intervention. The dosage of the probiotic powder is set at 1x10\^9 CFU/kg·bw·d, which means ingesting 10 billion CFU (Colony-Forming Units) of probiotics per kilogram of body weight per day. Before the intervention begins, a comprehensive health assessment and exercise capacity test will be conducted for the participants. Blood samples will be collected for baseline biochemical marker analysis. Participants will be instructed to take the probiotic powder once a day at the same time to ensure the consistency of the dosage and the standardization of the intervention. Participants will be asked to record their daily consumption, including the time of intake, any omissions, or discomfort. After the 8-week intervention, exercise ca
Eligibility Criteria
You may qualify if:
- Age Range: Individuals aged 20 to 30 years old.
- Health Status: Healthy, without chronic illnesses or disabilities.
- Athletic Background: Well-trained athletes with a history of regular physical activity.
- Lifestyle: No history of smoking or excessive alcohol consumption.
- Compliance and Consent: Capable of understanding and adhering to study protocols and willing to provide informed consent.
You may not qualify if:
- Chronic Illnesses: Individuals with unmanaged chronic diseases
- Substance Use: Current smokers or individuals with a history of substance abuse.
- Allergies and Supplements: History of food allergies or long-term use of nutritional supplements and medications.
- Probiotic and Antibiotic Use: Use of probiotics, fermented products, or antibiotics during the study period.
- Other Conditions: Pregnant or breastfeeding women, individuals with severe mental health conditions, or those participating in other clinical studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 26, 2024
First Posted
January 6, 2025
Study Start
February 1, 2025
Primary Completion
May 1, 2025
Study Completion
June 1, 2025
Last Updated
January 6, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share